Projects per year
Personal profile
Education
- 2022.07.03-2022.07.16 University of Oxford
- 2007 Ph.D., National Taiwan University Pathology
- 1998 MS, National Taiwan University Pathology
- 1996 BS.. China Medical University Medical Technology
Experience
- 2021- Associate Professor, Ph.D. Program in Medical Biotechnology, Taipei Medical University
- 2021- Associate Professor, School of Medical Laboratory Science and Biotechnology Assistant Professor, Taipei Medical University
- 2015-2021 Assistant Professor, Ph.D. Program in Medical Biotechnology, Taipei Medical University
- 2013-2021 Assistant Professor, School of Medical Laboratory Science and Biotechnology Assistant Professor, Taipei Medical University
- 2009 Seattle Childrens Research Institute fellow Ph.D
- 2007 Department of medical Laboratory Science and Biotechnology fellow Ph.D.
Awards
- 2011 53rd ASH abstract achievement awards- American Society of Hematology
- 2013 55rd ASH abstract achievement awards- American Society of Hematology
- 2013-2015 NSC University outstanding investigator recruitment award
- 2016 Excellent research paper award-Teachers and students joint academic research symposium (TMU)
- 2020 AAI Early Career Faculty Travel Grant - American Association of Immunologists (AAI)
Research Interests
- Immunotherapy
- Oncology
Fingerprint
Dive into the research topics where Chao-Lien Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CDK Inhibitor-Mediated PD-L1 Upregulation Enhances OC Responsiveness to CAR-Based Regimen Targeting
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
PAR1嵌合抗體T細胞及T調節細胞在臨床治療上的多功能應用
8/1/22 → 7/31/23
Project: B - Project of TMU › i - Other (Funded by TMU)
-
Targeting Ovarian Cancers with Chimeric Antigens Receptor (Cars) T-Cells Mediated Immunotherapy
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
嵌合抗原受體T細胞用於治療人類卵巢癌的免疫療法(2/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
Targeting Ovarian Cancers with Chimeric Antigens Receptor (Cars) T-Cells Mediated Immunotherapy(1/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
LncRNA MALAT1 facilitates ovarian cancer progression through promoting chemoresistance and invasiveness in the tumor microenvironment
Mao, T. L., Fan, M. H., Dlamini, N. & Liu, C. L., Oct 2021, In: International journal of molecular sciences. 22, 19, 10201.Research output: Contribution to journal › Article › peer-review
Open Access17 Citations (Scopus) -
The molecular landscape influencing prognoses of epithelial ovarian cancer
Liu, C. L., Yuan, R. H. & Mao, T. L., Jul 2021, In: Biomolecules. 11, 7, 998.Research output: Contribution to journal › Review article › peer-review
Open Access3 Citations (Scopus) -
4-methoxy sulfonyl paeonol inhibits hepatic stellate cell activation and liver fibrosis by blocking the TGF-β1/Smad, PDGF-BB/MAPK and Akt signaling pathways
Liao, Y. J., Wang, Y. H., Liu, C. L., Fang, C. C., Hsu, M. H. & Suk, F. M., Sept 1 2020, In: Applied Sciences (Switzerland). 10, 17, 5941.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Alterations of specific lymphocytic subsets with aging and age-related metabolic and cardiovascular diseases
Chen, Y. J., Liao, Y. J., Tram, V. T. N., Lin, C. H., Liao, K. C. & Liu, C. L., Oct 2020, In: Life. 10, 10, p. 1-16 16 p., 246.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-κB Signaling Pathway in Hepatic Stellate Cells
Wang, Y. H., Suk, F. M., Liu, C. L., Chen, T. L., Twu, Y. C., Hsu, M. H. & Liao, Y. J., Mar 31 2020, In: Frontiers in Pharmacology. 11, 388.Research output: Contribution to journal › Article › peer-review
Open Access13 Citations (Scopus)